These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17210867)

  • 1. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
    Lake-Bakaar G; Dustin L; McKeating J; Newton K; Freeman V; Frost SD
    Blood; 2007 Jan; 109(2):845-6. PubMed ID: 17210867
    [No Abstract]   [Full Text] [Related]  

  • 2. B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.
    Lake-Bakaar G; Jacobson I; Talal A
    Clin Exp Immunol; 2012 Nov; 170(2):231-7. PubMed ID: 23039894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.
    Petrarca A; Rigacci L; Caini P; Colagrande S; Romagnoli P; Vizzutti F; Arena U; Giannini C; Monti M; Montalto P; Matucci-Cerinic M; Bosi A; Laffi G; Zignego AL
    Blood; 2010 Jul; 116(3):335-42. PubMed ID: 20308604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
    Cacoub P; Terrier B; Saadoun D
    Presse Med; 2013 Apr; 42(4 Pt 2):523-7. PubMed ID: 23453499
    [No Abstract]   [Full Text] [Related]  

  • 5. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
    Dammacco F; Tucci FA; Lauletta G; Gatti P; De Re V; Conteduca V; Sansonno S; Russi S; Mariggiò MA; Chironna M; Sansonno D
    Blood; 2010 Jul; 116(3):343-53. PubMed ID: 20308602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.
    Sansonno D; De Re V; Lauletta G; Tucci FA; Boiocchi M; Dammacco F
    Blood; 2003 May; 101(10):3818-26. PubMed ID: 12506023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
    Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
    Saadoun D; Resche Rigon M; Sene D; Terrier B; Karras A; Perard L; Schoindre Y; Coppéré B; Blanc F; Musset L; Piette JC; Rosenzwajg M; Cacoub P
    Blood; 2010 Jul; 116(3):326-34; quiz 504-5. PubMed ID: 20439619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state.
    Morisco F; Del Vecchio Blanco G; Tuccillo C; Galli C; Cirino S; Caporaso N
    Res Virol; 1998; 149(5):277-82. PubMed ID: 9879605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How HCV has changed the approach to mixed cryoglobulinemia.
    Della Rossa A; Baldini C; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S115-23. PubMed ID: 19646357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
    Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
    J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinemia.
    Sansonno D; Tucci FA; Troiani L; Sansonno L; Dammacco F
    Curr Med Chem; 2008; 15(2):117-26. PubMed ID: 18220767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of humoral and cellular immunity in chronic hepatitis C patients of different staging].
    Masalova OV; Abdulmedzhidova AG; Morgunov KV; Grishchenko SV; Shkurko TV; Lakina EI; Kelli EI; L'vov DK; Kushch AA
    Vopr Virusol; 2003; 48(3):15-9. PubMed ID: 12894474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests.
    George SL; Gebhardt J; Klinzman D; Foster MB; Patrick KD; Schmidt WN; Alden B; Pfaller MA; Stapleton JT
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):154-62. PubMed ID: 12394793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
    Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
    J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cells and mixed cryoglobulinemia.
    Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
    Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.
    Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis.
    Holz LE; Yoon JC; Raghuraman S; Moir S; Sneller MC; Rehermann B
    Hepatology; 2012 Nov; 56(5):1602-10. PubMed ID: 22556016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell depletion in the treatment of mixed cryoglobulinemia.
    Sansonno D; Tucci FA; Montrone M; Troiani L; Sansonno L; Gatti P; Lauletta G
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S116-21. PubMed ID: 17936212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presence of hepatitis C virus in renal tissue in membranoproliferative glomerulonephritis and cryoglobulinemia].
    Tormo A; Rivera F; Muñoz C; Trigueros M
    Nefrologia; 2003; 23(2):165-8. PubMed ID: 12778882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.